Literature DB >> 14532855

Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine.

Kyu-Sung Lee1, Yong-Gil Na, Travis Dean-McKinney, Adam P Klausner, Jeremy B Tuttle, William D Steers.   

Abstract

PURPOSE: Because serotonin (5-HT) in the central nervous system may inhibit bladder activity, we postulated that depression associated with altered 5-HT function might be associated with overactive bladder (OAB). We examined a rat model of endogenous depression caused by lowering 5-HT for effects on voiding frequency (VF) and awake cystometry (CMG), and examined the effect of reversal using the selective serotonin reuptake inhibitor fluoxetine.
MATERIALS AND METHODS: Wistar rat pups were divided into 2 groups, namely clomipramine treated (CL) and saline control (SC). From postnatal days 8 to 21 each pup was injected with CL hydrochloride (22.5 mg/kg body weight) or an equal volume of saline. VF was assessed at 10 and 15 weeks. Behavioral correlates of depression were assessed using the forced swim test. At age 15 weeks CMG was performed. Fluoxetine (20 mg/kg daily) was administrated to a subset of SC/CL rats, and VF and CMG were repeated.
RESULTS: In CL rats immobility was increased when rats were submitted to the forced swim test, indicating depression. CL rats voided more frequently than the SC group at 10 and 15 weeks but the difference was significant only in females. CMG of female CL group showed decreased bladder capacity, micturition volume and intermicturition contractions compared with the SC group. Treatment with fluoxetine reversed these changes, as in SC rats.
CONCLUSIONS: These results support the hypothesis that OAB in a subgroup of depressed individuals may be associated with altered 5-HT function. It may explain reports of an association between depression and OAB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532855     DOI: 10.1097/01.ju.0000080648.01911.9a

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Identification of experimental bladder sensitivity among dysmenorrhea sufferers.

Authors:  Kevin M Hellman; Avisek Datta; Nicole D Steiner; Julia N Kane Morlock; Ellen F Garrison; Daniel J Clauw; Frank F Tu
Journal:  Am J Obstet Gynecol       Date:  2018-04-25       Impact factor: 8.661

2.  Estimating postvoid residual volume without measuring residual bladder volume during serial cystometrograms.

Authors:  Zachary C Danziger; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2016-04-20

3.  Postpartum depression, urge urinary incontinence, and overactive bladder syndrome: is there an association?

Authors:  Kathie L Hullfish; Dee E Fenner; Serge A Sorser; Jennifer Visger; Anita Clayton; William D Steers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-02-17

Review 4.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

5.  New insights into molecular targets for urinary incontinence.

Authors:  Manoj K Poonia; Ginpreet Kaur; Meena Chintamaneni; Ilesh Changela
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

6.  Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey.

Authors:  Heather J Litman; William D Steers; John T Wei; Varant Kupelian; Carol L Link; John B McKinlay
Journal:  Urology       Date:  2007-10-24       Impact factor: 2.649

7.  Brain serotoninergic nervous system is involved in bombesin-induced frequent urination through brain 5-HT7 receptors in rats.

Authors:  Takahiro Shimizu; Shogo Shimizu; Naoki Wada; Shun Takai; Nobutaka Shimizu; Youichirou Higashi; Katsumi Kadekawa; Tsuyoshi Majima; Motoaki Saito; Naoki Yoshimura
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

8.  The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Authors:  Yong June Yang; Jun Sung Koh; Hyo Jung Ko; Kang Joon Cho; Joon Chul Kim; Soo-Jung Lee; Chi-Un Pae
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

9.  Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms.

Authors:  Andrzej Wróbel; Anna Serefko; Ewa Poleszak; Tomasz Rechberger
Journal:  Int Urogynecol J       Date:  2016-05-03       Impact factor: 2.894

10.  Effectiveness and safety of moxibustion for alleviating symptoms of overactive bladder: A prospective, randomized controlled, crossover-design, pilot study.

Authors:  Hye-Yoon Lee; Young-Ju Yun; Jun-Yong Choi; Jin-Woo Hong; In Lee; Seong-Ha Park; Jung-Nam Kwon
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.